MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2016 International Congress

    Multimodal imaging assessment of nigrostriatal pathway in Parkinson’s disease using 11C-PE2I PET and neuromelanin-sensitive MR

    A. Martin-Bastida, N.P. Lao-Kaim, A.A. Roussakis, W. Li, M. Politis, N. Valle-Guzman, Z. Kefalopoulou, G. Paul, H. Widner, T. Foltynie, R. Barker, P. Piccini (London, United Kingdom)

    Objective: To evaluate the nigrostratal pathway with multimodal assessment using striatal 11C-PE2I PET and nigral Neuromelanin-sensitive MR in Parkinson's disease. Background: The main pathological features…
  • 2016 International Congress

    Striatal PDE10 expression in Parkinson’s disease (PD) and healthy controls using [18F]MNI-659 PET imaging

    D.S. Russell, D.L. Jennings, O. Barret, G.D. Tamagnan, D. Alagille, J.P. Seibyl, K.L. Marek (New Haven, CT, USA)

    Objective: To evaluate the feasibility of [18F]MNI-659 PET, a striatal PDE10A imaging tracer, as a imaging biomarker in PD. Background: PDE10 is highly and specifically…
  • 2016 International Congress

    Comparison of DAT and DOPA PET tracer for assessing severity and progression in patients with Parkinson’s disease

    W. Li, N.P. Lao-Kaim, A.A. Roussakis, A. Martin-Bastida, C. Loane, N. Valle-Guzman, Z. Kefalopoulou, M. Politis, T. Foltynie, R.A. Barker, P. Piccini (London, United Kingdom)

    Objective: The aims of this study were to quantify striatal uptake of 18F-DOPA and 11C-PE2I in the same group of PD patients, to assess the…
  • 2016 International Congress

    Persistent drug-induced parkinsonism with normal dopamine transporter imaging

    J.W. Lee, J.Y. Hong, J.S. Oh, I. Lee, J.S. Kim, Y.H. Sohn, P.H. Lee (Wonju, Korea)

    Objective: We investigated whether patients with persistent drug-induced parkinsonism (DIP) showing visually normal dopamine transporter (DAT) imaging had minimal changes in striatal DAT activity using…
  • 2016 International Congress

    Cerebellar GABA-A receptor activity is inversely correlated with gait speed in Parkinson’s disease

    N.I. Bohnen, K.A. Frey, R.A. Koeppe, P.J.H. Scott, M.L.T.M. Muller (Ann Arbor, MI, USA)

    Objective: To investigate the relationship between regional cerebral expression of benzodiazepine receptors and gait speed in Parkinson's disease (PD). Background: Flumazenil is a short-acting intravenously…
  • 2016 International Congress

    Frontal dysfunction in Tourette syndrome: A PET-FDG study

    R. García-Ramos, N. Gonzalez, E. Lopez Valdes, F. Alonso, N. Cabrera, I. Parees, M.J. Catalán, J. Matías-Guíu Antem (Madrid, Spain)

    Objective: Our objective was study the metabolism of brain in a group of patients with Tourette´s Syndrome. Background: The pathophysiology and anatomical basis of Tourette…
  • 2016 International Congress

    Dopaminergic and metabolic network activities in onset-related subtypes of Parkinson’s disease: A dual-tracer positron emission tomography study

    F.T. Liu, J.J. Ge, J.J. Wu, Z.T. Ding, C.T. Zuo, J. Wang (Shanghai, People's Republic of China)

    Objective: The current study investigated the differences of dopaminergic and metabolic patterns between the young-onset subtype of Parkinson's disease (YOPD) and the late-onset subtype (LOPD)…
  • 2016 International Congress

    Phenotypes in Essential Tremor: Gait analysis and imaging study

    E. Boutin, T. Witjas, R. Carron, J. Regis, E. Guedj, J.P. Azulay, M. Vaugoyeau (Marseille, France)

    Objective: If essential tremor (ET) is the most common movement disorder in adults, its pathophysiology remains poorly understood and few data are available as for…
  • 2016 International Congress

    Novel PET Tracers of alpha-synuclein for the diagnosis of Parkinson’s disease

    E. Tsika, A. Davranche, J. Molette, E. Gabellieri, S. Papin, S. Nampally, H. Kroth, D. Lowe, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

    Objective: The aim of our project is to develop small molecular weight compounds (Morphomers™) which bind selectively to alpha-synuclein (aSyn) aggregates, in order to generate…
  • 2016 International Congress

    Substantia nigra α4β2 nicotinic cholinergic receptor expression correlates with tremor in Parkinson’s disease

    M. Muller, R. Albin, N. Bohnen (Ann Arbor, MI, USA)

    Objective: To investigate the relationship between tremor and α4β2 nicotinic cholinergic receptor (nAChR) expression in brain regions associated with tremor in Parkinson's disease (PD), including…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley